MedPath

Obseravtional study evaluating the perfomance of the bioabsorbable stent (scaffold) in every day clinical practice

Recruiting
Conditions
Patients presenting with NSTEMI stable or unstable angina, or silent
Registration Number
NL-OMON27706
Lead Sponsor
Investigator Initiated study (Erasmus MC)
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

1. Patient presenting with NSTEMI stable or unstable angina , or silent ischemia caused by a de novo stenotic lesion in a native previous untreated coronary artery.

2. Dmax (proximal and distal mean lumen diameter) within the upper limit of 3.8 mm and the lower limit of 2.0 mm by online QCA (at the moment only for the 2.5 mm and 3.5 mm devices)

Exclusion Criteria

1. Previous CABG

2. Cardiogenic shock

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Major Adverse Cardiac Events (MACE): defined as cardiac death, re-MI, emergent bypass surgery (CABG), or clinically driven target lesion revascularization (TLR) by percutaneous or surgical methods at 12 months post-procedure
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath